Correlation Between Enlivex Therapeutics and Protext Mobility
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Protext Mobility at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Protext Mobility into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Protext Mobility, you can compare the effects of market volatilities on Enlivex Therapeutics and Protext Mobility and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Protext Mobility. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Protext Mobility.
Diversification Opportunities for Enlivex Therapeutics and Protext Mobility
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enlivex and Protext is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Protext Mobility in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protext Mobility and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Protext Mobility. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protext Mobility has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Protext Mobility go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Protext Mobility
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Protext Mobility. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 1.8 times less risky than Protext Mobility. The stock trades about -0.04 of its potential returns per unit of risk. The Protext Mobility is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 0.15 in Protext Mobility on September 13, 2024 and sell it today you would lose (0.01) from holding Protext Mobility or give up 6.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Protext Mobility
Performance |
| Timeline |
| Enlivex Therapeutics |
| Protext Mobility |
Enlivex Therapeutics and Protext Mobility Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Protext Mobility
The main advantage of trading using opposite Enlivex Therapeutics and Protext Mobility positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Protext Mobility can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protext Mobility will offset losses from the drop in Protext Mobility's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Protext Mobility vs. Living Cell Technologies | Protext Mobility vs. Multicell Techs | Protext Mobility vs. Institute of Biomedical | Protext Mobility vs. Health Sciences Gr |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets |